Drug Information Related to Paraplatin
Back
01. Spector, Roseman & Kodroff, P.C. Say Federal Judge Allows Consumer...
BOSTON -- In a national class action lawsuit filed by Spector, Roseman & Kodroff, P.C. on behalf of consumers and third party payors claiming prescription drug overpayments, U.S. District Judge Patti B. Saris Sari (särē`), city (1991 pop. 167,602),...
02. Cell Pathways and Bristol-Myers Squibb to Conduct Study in First-Line ...
Business Editors & Health/Medical Writers HORSHAM, Pa.--(BW HealthWire)--May 3, 2001 Cell Pathways, Inc. (Nasdaq:CLPA CLPA - Connection-Level Performance Analysis) today announced that the company and Bristol-Myers Squibb Company plan to cooperate in supporting...
03. Average Increase in Price of Cancer Drugs Below CPI Trend. - Free ......
RESEARCH TRIANGLE PARK, N.C. -- Cancer e search Incorporated, an oncology market research consulting firm, conducted a study to measure the increase in the price of cancer drug therapy in the United States. Based on a study of 63 cancer drugs, which represent approxi...
04. Gain Strategic Insight into 243 Lung Cancer Drugs Currently in ......
DUBLIN, Ireland -- Research and Markets
(http://www.researchandmarkets.com/reportinfo.asp?report_id=316584) has
announced the addition of Lung Cancer Drug Pipeline Update 2006 to their
offering.
According to the American Cancer Society approximately 175,000
p...
05. Corvas appoints Picker as executive vice president and chief operating...
SAN DIEGO--(BUSINESS WIRE)--Feb. 7, 1996--Corvas International Inc. (NNM:CVAS CVAS - Configuration Verification Accounting System (NASA)) Wednesday announced the appointment of Donald H. Picker picker: see harvester., Ph.D., 50, as executive vice president and ch...
06. Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is ......
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c34737) has announced the addition of Analytical Tool - Current & Future Lung Cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the l...
07. Research and Markets: Injectable Generic Drugs: Prospects ...
DUBLIN, Ireland -- Research and Markets
(http://www.researchandmarkets.com/research/9d0b85/injectable_generic)
has announced the addition of the "Injectable Generic Drugs:
Prospects & Opportunities to 2013" report to their offering.
This report provides:
...
08. OSI Pharmaceuticals Announces Initiation of a Phase III Clinical Trial...
Business Editors MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 20, 2001 OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), announced today that its global partner Roche has initiated a Phase III clinical trial evaluating the use of Tarceva(TM) (OSI-774) in combination with gemcitab...
09. Genentech Reports 34 Percent Increase in Product Sales for Third ......
Business EditorsSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 10, 200125 Percent Increase in Earnings Per Share and 22 Percent Increasein Net Income, Exclusive of Impact of RedemptionGenentech, Inc. (NYSE:DNA) today announced a 25 percent increase in
earnings pe...
10. CELL PATHWAYS REPORTS DECREASED NET LOSS FOR SECOND QTR. - Free Online...
Cell Pathways, Inc. (Nasdaq:CLPA), Horsham, Pa., has reported
financial results for the second quarter and six months ended June 30,
2001.
For the second quarter ended June 30, 2001, the company reported a
net loss of $4.9 million, or $2.3 million less than t...
11. NCCN Announces Important Updates to Ovarian Cancer Clinical Practice ....
JENKINTOWN, Pa. -- The National Comprehensive Cancer Network (NCCN) announces updates to the NCCN Ovarian Cancer Guidelines. The NCCN Clinical Practice Guidelines in Oncology(TM) are widely recognized and applied as the standard for clinical policy in oncology in both...
12. From a week in practice | American Family Physician | Find Articles at...
Monday
...
13. Despite the national economic downturn, the pharmaceutical industry .....
Through economic upturns, downturns and subsequent recovery, one industry continues to remain economitally viable. The pharmaceutical industry in the year 2000 earned a 17 percent return on both revenues and assets, making it the top performing industry] and the most pr...
14. Lung Cancer; Treatment | NWHRC Health Center - Lung Cancer | Find ......
The three primary forms of treatment for lung cancer are surgery, radiation therapy and chemotherapy. One or more of these therapies may be used to treat lung cancer, depending on the type and stage of the disease as well as your age and overall health. When you're co...
15. Teva Announces Settlement of Carboplatin Litigation with Bristol-Myers...
Business Editors/Health/Medical Writers
...
16. Bristol-Myers may sell line of over-the-counter drugs | Deseret News ....
NEW YORK -- Bristol-Myers Squibb Co. is in talks to sell its consumer over-the-counter drug line, which includes pain relievers Excedrin and Bufferin, cold medicine Comtrex and Keri lotions, according to published reports.
...
17. APhA condemns pharmacist charged with diluting cancer/chemo drugs ......
KANSAS CITY, Mo. -- Criminal allegations were raised against a Kansas City pharmacist last month for diluting patients' chemotherapy drugs. The pharmacists met swift condemnation from industry leaders who characterized the incident as "an uncommon occurrence.&quo...
18. Carboplatin | Encyclopedia of Cancer | Find Articles at BNET
Definition
...
